December 26, 2014 12:36 AM ET

Biotechnology

Company Overview of Avalon Pharmaceuticals, Inc.

Executive Profile

Chris H. Takimoto M.D., Ph.D.

Member of Clinical Advisory Board, Avalon Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 Board Members in 0 different organizations across 0 different industries.

----

Background

Dr. Chris H. Takimoto, M.D., Ph.D., serves as Director of Pharmacology and the Zachry Chair of Translational Research at the Institute for Drug Development. Dr. Takimoto is an expert in Phase I and early clinical development of cancer therapies. Dr. Takimoto served as Member of Clinical Advisory Board of Avalon Pharmaceuticals, Inc. since January 2007.

Corporate Headquarters

20358 Seneca Meadows Parkway
Germantown, Maryland 20876

United States

Phone: 301-556-9900
Fax: 301-556-9910

Board Members Memberships

There is no Board Members Memberships data available.

Education

There is no Education data available.

Other Affiliations

There is no Company Affiliations data available.

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Avalon Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.